Price (delayed)
$113.86
Market cap
$198.1B
P/E Ratio
35.81
Dividend/share
$2.16
EPS
$3.18
Enterprise value
$205.87B
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott
Highlights
Abbott Laboratories's debt has decreased by 12% YoY
Abbott Laboratories's net income has increased by 8% YoY
ABT's P/E is 7% above its last 4 quarters average of 33.6
Key stats
What are the main financial stats of ABT
Market
Valuations
Earnings
Shares outstanding
1.74B
Market cap
$198.1B
Enterprise value
$205.87B
Price to earnings (P/E)
35.81
Price to book (P/B)
5.01
Price to sales (P/S)
4.87
EV/EBIT
28.93
EV/EBITDA
19.87
EV/Sales
5.06
Revenue
$40.73B
EBIT
$7.12B
EBITDA
$10.36B
Free cash flow
$5.65B
Per share
Balance sheet
Liquidity
EPS
$3.18
Free cash flow per share
$3.24
Book value per share
$22.74
Revenue per share
$23.36
TBVPS
$24.03
Total assets
$73.02B
Total liabilities
$33.46B
Debt
$14.75B
Equity
$39.56B
Working capital
$9.36B
Debt to equity
0.37
Current ratio
1.68
Quick ratio
1.02
Net debt/EBITDA
0.75
Margins
Efficiency
Dividend
EBITDA margin
25.4%
Gross margin
55.2%
Net margin
13.6%
Operating margin
15.9%
Return on assets
7.6%
Return on equity
14.3%
Return on invested capital
20.2%
Return on capital employed
12%
Return on sales
17.5%
Dividend yield
1.9%
DPS
$2.16
Payout ratio
67.9%
ABT stock price
How has the Abbott Laboratories stock price performed over time
Intraday
0.67%
1 week
0.52%
1 month
3.98%
1 year
12.11%
YTD
3.44%
QTD
9.58%
Financial performance
How have Abbott Laboratories's revenue and profit performed over time
Revenue
$40.73B
Gross profit
$22.5B
Operating income
$6.48B
Net income
$5.56B
Gross margin
55.2%
Net margin
13.6%
Abbott Laboratories's net income has increased by 8% YoY
The operating income has grown by 6% YoY
Abbott Laboratories's net margin has increased by 6% YoY but it has decreased by 2.9% QoQ
Abbott Laboratories's operating margin has increased by 4.6% YoY
Growth
What is Abbott Laboratories's growth rate over time
Valuation
What is Abbott Laboratories stock price valuation
P/E
35.81
P/B
5.01
P/S
4.87
EV/EBIT
28.93
EV/EBITDA
19.87
EV/Sales
5.06
The EPS has grown by 8% YoY
ABT's P/E is 7% above its last 4 quarters average of 33.6
ABT's equity is up by 6% year-on-year
ABT's price to book (P/B) is 5% lower than its 5-year quarterly average of 5.3 but 4.4% higher than its last 4 quarters average of 4.8
ABT's P/S is 6% above its last 4 quarters average of 4.6
Efficiency
How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has increased by 9% YoY
ABT's ROE is down by 2.7% from the previous quarter but it is up by 2.1% YoY
The ROS has grown by 2.3% YoY
Dividends
What is ABT's dividend history
DPS
$2.16
Dividend yield
1.9%
Payout ratio
67.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Abbott Laboratories financials performed over time
The total assets is 118% more than the total liabilities
Abbott Laboratories's total liabilities has decreased by 7% YoY
ABT's quick ratio is up by 7% since the previous quarter and by 2% year-on-year
Abbott Laboratories's debt is 63% lower than its equity
Abbott Laboratories's debt to equity has decreased by 18% YoY
Abbott Laboratories's debt has decreased by 12% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.